It is known that the persistently active YAP1 expression abolishes the action of the inhibitors, which leads to the hypothesis that impairment of the YAP1/TAZ/TEAD signaling is a prerequisite for the effectiveness of Verteporfin and CA3 in mesothelioma cells. Here, YAP1 is linked to mesothelioma.